Phibro Animal Health Co. (NASDAQ:PAHC) Shares Acquired by Cardinal Capital Management

Cardinal Capital Management boosted its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 5.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 68,442 shares of the company’s stock after buying an additional 3,456 shares during the period. Cardinal Capital Management owned 0.17% of Phibro Animal Health worth $1,437,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Geode Capital Management LLC increased its stake in shares of Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after acquiring an additional 27,201 shares during the period. Barclays PLC boosted its stake in Phibro Animal Health by 25.7% during the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock valued at $3,228,000 after purchasing an additional 29,271 shares in the last quarter. Algert Global LLC boosted its stake in Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after purchasing an additional 59,850 shares in the last quarter. FMR LLC raised its stake in shares of Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock worth $885,000 after buying an additional 7,270 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its stake in shares of Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after buying an additional 729 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Analysts Set New Price Targets

PAHC has been the subject of a number of research analyst reports. Barclays upped their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Stock Performance

Shares of PAHC opened at $25.77 on Tuesday. Phibro Animal Health Co. has a one year low of $11.81 and a one year high of $26.49. The company has a 50-day moving average of $22.17 and a two-hundred day moving average of $21.99. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.69. The stock has a market cap of $1.04 billion, a price-to-earnings ratio of 53.69, a PEG ratio of 0.53 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, equities research analysts expect that Phibro Animal Health Co. will post 1.94 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.86%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s payout ratio is 100.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.